These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12190716)

  • 1. The influence of successful prophylactic drug treatment on cognitive dysfunction in bipolar disorders.
    Wolf T; Müller-Oerlinghausen B
    Bipolar Disord; 2002 Aug; 4(4):263-70. PubMed ID: 12190716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attachment, dysfunctional attitudes, self-esteem, and association to depressive symptoms in patients with mood disorders.
    Fuhr K; Reitenbach I; Kraemer J; Hautzinger M; Meyer TD
    J Affect Disord; 2017 Apr; 212():110-116. PubMed ID: 28160683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social adjustment and self-esteem in remitted patients with mood disorders.
    Serretti A; Cavallini MC; Macciardi F; Namia C; Franchini L; Souery D; Lipp O; Bauwens F; Smeraldi E; Mendlewicz J
    Eur Psychiatry; 1999 Jun; 14(3):137-42. PubMed ID: 10572338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.
    Kleindienst N; Greil W
    Neuropsychobiology; 2000; 42 Suppl 1():2-10. PubMed ID: 11093063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.
    Denicoff KD; Smith-Jackson EE; Disney ER; Ali SO; Leverich GS; Post RM
    J Clin Psychiatry; 1997 Nov; 58(11):470-8. PubMed ID: 9413412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients.
    Hartong EG; Moleman P; Hoogduin CA; Broekman TG; Nolen WA;
    J Clin Psychiatry; 2003 Feb; 64(2):144-51. PubMed ID: 12633122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients.
    Simhandl C; König B; Amann BL
    J Clin Psychiatry; 2014 Mar; 75(3):254-62; quiz 263. PubMed ID: 24717379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of self-esteem in bipolar disorder: comparisons among remitted bipolar patients, remitted unipolar patients and healthy controls.
    Knowles R; Tai S; Jones SH; Highfield J; Morriss R; Bentall RP
    Bipolar Disord; 2007 Aug; 9(5):490-5. PubMed ID: 17680919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
    Houston JP; Ahl J; Meyers AL; Kaiser CJ; Tohen M; Baldessarini RJ
    J Clin Psychiatry; 2006 Aug; 67(8):1246-52. PubMed ID: 16965203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.
    Segal ZV; Kennedy S; Gemar M; Hood K; Pedersen R; Buis T
    Arch Gen Psychiatry; 2006 Jul; 63(7):749-55. PubMed ID: 16818864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A history of substance abuse complicates remission from acute mania in bipolar disorder.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1999 Nov; 60(11):733-40. PubMed ID: 10584760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study.
    Xu G; Lin K; Rao D; Dang Y; Ouyang H; Guo Y; Ma J; Chen J
    J Affect Disord; 2012 Feb; 136(3):328-39. PubMed ID: 22169253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.
    Angst J; Azorin JM; Bowden CL; Perugi G; Vieta E; Gamma A; Young AH;
    Arch Gen Psychiatry; 2011 Aug; 68(8):791-8. PubMed ID: 21810644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive vulnerability in patients with bipolar disorder.
    Scott J; Stanton B; Garland A; Ferrier IN
    Psychol Med; 2000 Mar; 30(2):467-72. PubMed ID: 10824667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.